| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.094 | 0.03 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.04 |